Advances in application of multimodal ultrasound imaging in diagnosis of renal tumors

doi:10.3877/cma.j.issn.2095-3216.2023.06.009

Abstract

Abstract:

Preoperative renal ultrasound imaging can assist in determining if the lesion is benign, which is beneficial for clinical doctors to make reasonable decisions as soon as possible and provide timely treatment for the patients. Multimodal ultrasound imaging techniques include conventional ultrasound (CUS), Doppler ultrasound, elastography imaging (EI), contrast-enhanced ultrasound (CEUS), super microvascular imaging (SMI), ultrasound-guided attenuation parameter (UGAP), and ultrasound molecular imaging (USMI), etc. These multimodal ultrasound imaging techniques can provide additional evidence for the diagnosis and treatment of renal tumors through evaluating the morphology, blood perfusion, and internal structure of the tumors. This article reviewed the latest progress in the clinical application of multimodal ultrasound imaging techniques in renal tumors.

Key words: Multi-modal ultrasound imaging, Renal tumors, Diagnosis

Jingbo Li, Jianing Zhu, Luda Song, Yukun Luo, Qiuyang Li. Advances in application of multimodal ultrasound imaging in diagnosis of renal tumors[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(06): 349-353.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2023.06.009

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2023/V12/I06/349

Figures/Tables 1

References 37

[1]	Campbell SC, Clark PE, Chang SS, et al. Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I [J]. J Urol, 2021, 206(2): 199-208.
[2]	Zhu JN, Li N, Zhao P, et al. Contrast-enhanced ultrasound (CEUS) of benign and malignant renal tumors: distinguishing CEUS features differ with tumor size [J]. Cancer Med, 2023, 12(3): 2551-2559.
[3]	Furrer MA, Spycher SCJ, Büttiker SM, et al. Comparison of the diagnostic performance of contrast-enhanced ultrasound with that of contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging in the evaluation of renal masses: a systematic review and meta-analysis [J]. Eur Urol Oncol, 2020, 3(4): 464-473.
[4]	Roussel E, Campi R, Amparore D, et al. Expanding the role of ultrasound for the characterization of renal masses [J]. J Clin Med, 2022, 11(4): 1112.
[5]	郑丽丽，任新平，詹维伟，等. 常规超声结合超声造影对肾透明细胞癌与肾血管平滑肌脂肪瘤的鉴别诊断价值[J]. 第二军医大学学报，2021, 42(6): 609-616.
[6]	郑云，王春光，王玉玲，等. 高回声小肾癌与错构瘤超声表现的对比分析[J]. 医学影像学杂志，2020, 30(3): 428-431.
[7]	柴晓明，李英丽，李子彦，等. MRI多参数定量分析在鉴别肾透明细胞癌与乏脂型血管平滑肌脂肪瘤中的应用[J]. 中国中西医结合影像学杂志，2019, 17(6): 583-586.
[8]	孙霞，赵玉珍，孙心平，等. 肾肿瘤的彩色多普勒超声观察[J]. 中国超声诊断杂志，2003, 4(1): 45-46, 82.
[9]	Yoo SY, Kim IO, Kim YI, et al. Power Doppler imaging in acute renal vein occlusion and recanalization: a canine model [J]. Korean J Radiol, 2008, 9(2): 128-133.
[10]	Leung KY, Wan YL. Update on color flow imaging in obstetrics [J]. Life (Basel), 2022, 12(2): 226.
[11]	张岱. 多模式超声血流显像技术对不同大小肾肿瘤诊断的比较分析[D]. 天津：天津医科大学，2020.
[12]	Adler DD, Carson PL, Rubin JM, et al. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings [J]. Ultrasound Med Biol, 1990, 16(6): 553-559.
[13]	傅庆印，刘莹，刘启平，等. 彩色多普勒能量图联合超微血管成像技术对乳腺肿块的诊断价值[J]. 医学影像学杂志，2021, 31(3): 445-448.
[14]	Mao Y, Mu J, Zhao J, et al. The value of superb microvascular imaging in differentiating benign renal mass from malignant renal tumor: a retrospective study [J]. Br J Radiol, 2018, 91(1082): 20170601.
[15]	Gallan AJ, Antic T. Clinicopathologic features of small renal masses associated with distant metastatic disease [J]. Am J Clin Pathol, 2020, 153(5): 613-617.
[16]	Yeh HC, Halton KP, Shapiro RS, et al. Junctional parenchyma: revised definition of hypertrophic column of Bertin [J]. Radiology, 1992, 185(3): 725-732.
[17]	Luo JL, Chen JS, Sun Y, et al. Quantitative contrast-enhanced ultrasound of renal perfusion: a technology for the assessment of early diabetic nephropathy in cynomolgus macaques with type 2 diabetes mellitus [J]. Abdom Radiol (NY), 2019, 44(5): 1850-1857.
[18]	Benozzi L, Cappelli G, Granito M, et al. Contrast-enhanced sonography in early kidney graft dysfunction [J]. Transplant Proc, 2009, 41(4): 1214-1215.
[19]	郑丽丽，任新平，詹维伟，等. 常规超声结合超声造影对肾透明细胞癌与肾血管平滑肌脂肪瘤的鉴别诊断价值[J]. 第二军医大学学报，2021, 42(6): 609-616.
[20]	Zhao P, Zhu JN, Wang LK, et al. Comparative diagnostic performance of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for differentiating clear cell and non-clear cell renal cell carcinoma [J]. Eur Radiol, 2023, 33(5): 3766-3774.
[21]	马金秋，王洋，姚得顺. 乳腺癌患者超声造影检查肿瘤微血管灌注特征与病理学关系探究[J]. 中国医师进修杂志，2023, 46(2): 172-175.
[22]	Shi XL, Liu RF, Xia Y, et al. Qualitative and quantitative superb vascular imaging in the diagnosis of thyroid nodules ≤10 mm based on the Chinese Thyroid Imaging Reporting and Data System 4 (C-TIRADS 4) [J]. Quant Imaging Med Surg, 2023, 13(5): 3213-3221.
[23]	Chen M, Fu XH, Shen Y. Evaluation of multimode color Doppler flow imaging in the diagnosis of solid renal tumor [J]. Contrast Media Mol Imaging, 2021, 2021: 6656877.
[24]	Sigrist RMS, Liau J, Kaffas AE, et al. Ultrasound elastography: review of techniques and clinical applications [J]. Theranostics, 2017, 7(5): 1303-1329.
[25]	Shiina T, Nightingale KR, Palmeri ML, et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 1: basic principles and terminology [J]. Ultrasound Med Biol, 2015, 41(5): 1126-1147.
[26]	Cè M, Felisaz PF, Alì M, et al. Ultrasound elastography in chronic kidney disease: a systematic review and meta-analysis [J]. J Med Ultrason (2001), 2023, 50(3): 381-415.
[27]	Thaiss WM, Bedke J, Kruck S, et al. Can contrast-enhanced ultrasound and acoustic radiation force impulse imaging characterize CT-indeterminate renal masses? A prospective evaluation with histological confirmation [J]. World J Urol, 2019, 37(7): 1339-1346.
[28]	Cai Y, Li F, Li Z, et al. Diagnostic performance of ultrasound shear wave elastography in solid small (≤4 cm) renal parenchymal masses [J]. Ultrasound Med Biol, 2019, 45(9): 2328-2337.
[29]	Göya C, Daggulli M, Hamidi C, et al. The role of quantitative measurement by acoustic radiation force impulse imaging in differentiating benign renal lesions from malignant renal tumors [J]. Radiol Med, 2015, 120(3): 296-303.
[30]	秦芩，王丹丹，党文珠，等. 实时剪切波弹性成像技术在肾脏疾病中的应用进展[J]. 临床肾脏病杂志，2020, 20(10): 846-849.
[31]	Bende F, Sporea I, Şirli R, et al. Ultrasound-guided attenuation parameter (UGAP) for the quantification of liver steatosis using the controlled attenuation parameter (CAP) as the reference method [J]. Med Ultrason, 2021, 23(1): 7-14.
[32]	Imajo K, Toyoda H, Yasuda S, et al. Utility of ultrasound-guided attenuation parameter for grading steatosis with reference to MRI-PDFF in a large cohort [J]. Clin Gastroenterol Hepatol, 2022, 20(11): 2533-2541.e7.
[33]	柴晓明，李英丽，李子彦，等. MRI多参数定量分析在鉴别肾透明细胞癌与乏脂型血管平滑肌脂肪瘤中的应用[J]. 中国中西医结合影像学杂志，2019, 17(6): 583-586.
[34]	杜怡熳，李秋洋，姜波，等. 超声引导衰减参数技术在肾占位病变的良恶性鉴别中的应用[J/CD]. 中华医学超声杂志(电子版), 2022, 19(7): 694-700.
[35]	Helbert A, Von Wronski M, Colevret D, et al. Ultrasound molecular imaging with BR55, a predictive tool of antiangiogenic treatment efficacy in a chemo-induced mammary tumor model [J]. Invest Radiol, 2020, 55(10): 657-665.
[36]	Rojas JD, Lin F, Chiang YC, et al. Ultrasound molecular imaging of VEGFR-2 in clear-cell renal cell carcinoma tracks disease response to antiangiogenic and notch-inhibition therapy [J]. Theranostics, 2018, 8(1): 141-155.
[37]	Willmann JK, Bonomo L, Testa AC, et al. Ultrasound molecular imaging with BR55 in patients with breast and ovarian lesions: first-in-human results [J]. J Clin Oncol, 2017, 35(19): 2133-2140.

Please choose a citation manager

Content to export